Impac to review financial statements

Radiation oncology developer Impac Medical Systems of Mountain View, CA, is reviewing previous financial statements to see if some revenue recognized in previous quarters should be shifted to later periods.

Impac said that its review of the financial statements so far indicates that the timing of some revenues may have been incorrect. The company said that it believes that none of the affected revenues are invalid, and that there is no evidence to indicate any fraudulent behavior or intent to mislead investors.

In light of the review, the company said it was postponing its earning release for the first quarter of 2004. The company will discuss its first-quarter results and the outcome of the revenue-recognition review as soon as it is completed.

By staff writers
February 6, 2004

Related Reading

Impac signs M.D. Anderson, July 25, 2003

Impac establishes Philips relationship, March 12, 2003

Impac renews Siemens relationship, April 24, 2002

Threatened U.S. challenge kills Impac/Varian merger, November 8, 2000

Varian to buy Impac Medical Systems, June 7, 2000

Copyright ©

Page 1 of 461
Next Page